Jeanne Rodman
Nurse Practitioner · Seymour, MONPI 1700876059
Payments from drug & device makers
Across 144 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$916
- Lilly USA, LLC$366
- Novo Nordisk$248
- Abbott$157
- GSK$151
- Otsuka America Pharmaceutical, Inc.$116
- plus $565 from 13 others
What the payments were for
- Food & beverage$2,47398%
- Education$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 46 | $916 |
| Lilly USA, LLC | 20 | $366 |
| Novo Nordisk | 18 | $248 |
| Abbott | 8 | $157 |
| GSK | 10 | $151 |
| Otsuka America Pharmaceutical, Inc. | 7 | $116 |
| AbbVie | 5 | $104 |
| Exact Sciences | 6 | $94 |
| E.r. Squibb & Sons, L.L.C. | 6 | $89 |
| Lundbeck LLC | 4 | $64 |
| Pfizer | 4 | $57 |
| Astellas Pharma US Inc | 2 | $39 |
| Boehringer Ingelheim | 2 | $32 |
| Edwards Lifesciences | 1 | $17 |
| Novartis | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,518 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $75,242 |
| OzempicSemaglutide | 59 | $58,727 |
| FarxigaDapagliflozin Propanediol | 49 | $50,526 |
| MounjaroTirzepatide | 43 | $46,500 |
| JardianceEmpagliflozin | 43 | $45,389 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $34,611 |
| JanuviaSitagliptin Phosphate | 25 | $29,326 |
| Spiriva RespimatTiotropium Bromide | 30 | $23,328 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $15,331 |
| XareltoRivaroxaban | 19 | $11,555 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $10,367 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $9,602 |
| DuleraMometasone/Formoterol | 15 | $6,303 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $5,138 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 16 | $4,773 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $916 | $94,739104 claims |
| PfizerEliquis | $57 | $75,24277 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $32 | $68,71773 claims |
| Novo NordiskOzempic | $248 | $58,72759 claims |
| Lilly USA, LLCMounjaro | $366 | $46,50043 claims |
| MerckJanuvia, Dulera | $13 | $35,62940 claims |
| GSKTrelegy Ellipta, Arexvy | $151 | $20,10432 claims |
| AbbVieSynthroid | $104 | $2,13531 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Other nurse practitioner in Seymour
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
- Amanda HumbersFarmington$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.